Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) -Successful Closure Of US FDA Inspection At Piramal PharmaS Manufacturing Facility Located At Turbhe
10:59 AM, 12th May 2025
Sucessful closure of US FDA Inspection at Piramal Pharmas Manufacturing Facility located at Turbhe.